InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[johan31]

Hard to say.....all depends on results doesn't it? Ino has a bigger pipeline although only 2 phase2. The rest being phase1 and preclinical. Outstanding data so far in all trials & preclinicals. I don't think the market will give Ino it's due until good phase2 results are released or large partnership is announced which Kim has said numerous times they are in continuing discussions. DNA vaccines have a history of less than spectacular data which, imo, has been due to the inability to get the vaccine into the cell membrane. Ino has seemed to solved that with their proprietary & patented electroporation devices.

I got invested with NVIV because of Bob Langer, initially. Don't care too much for Reynold's personality and way too optimistic timelines. He is very motivated though. I like their scientific team and they have good connections in the FDA realm. I've taken profits twice since approval and am waiting to get more on these dips. I don't think we've seen the last of the dips either, although that is just my opinion. It'll ramp up again for trial commencement announcement which could really drive the price in the short term. Afterwards all depends on results.

So both companies are different but exciting. I currently am invested in both with more in INO at the moment.

GLTA

johan